Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

The ICON and AGO Collaborators

doi:10.1016/S0140-6736(03)13718-X

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

The ICON and AGO Collaborators

Research output: Contribution to journal › Article › peer-review

1074 Citations (Scopus)

Original language	English
Pages (from-to)	2099-2106
Number of pages	8
Journal	The Lancet
Volume	361
Issue number	9375
DOIs	https://doi.org/10.1016/S0140-6736(03)13718-X
Publication status	Published - 21 Jun 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(03)13718-X

Cite this

@article{04f5fc28341440ab9c65209c1021df64,

title = "Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial",

author = "Swart, {Ann Marie} and {The ICON and AGO Collaborators}",

year = "2003",

month = jun,

day = "21",

doi = "10.1016/S0140-6736(03)13718-X",

language = "English",

volume = "361",

pages = "2099--2106",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9375",

}

TY - JOUR

T1 - Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

AU - Swart, Ann Marie

AU - The ICON and AGO Collaborators

PY - 2003/6/21

Y1 - 2003/6/21

U2 - 10.1016/S0140-6736(03)13718-X

DO - 10.1016/S0140-6736(03)13718-X

M3 - Article

VL - 361

SP - 2099

EP - 2106

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9375

ER -